共 30 条
- [21] Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JS']JSTCT) [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E447 - E450
- [22] Clinical outcomes of allogeneic haematopoietic stem cell transplantation with intravenous busulfan-based reduced-intensity conditioning for acute myeloid leukaemia: a nationwide retrospective study from the adult AML working group of JS']JSHCT [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S62 - S62
- [23] INFLUENCE OF GRAFT-VERSUS-HOST DISEASE ON LATE RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES: A NATIONWIDE RETROSPECTIVE STUDY FROM THE LATE COMPLICATIONS AND QUALITY-OF-LIFE WORKING GROUP OF JS']JSHCT [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S85 - S86
- [24] Equivalent outcome between reduced-intensity versus conventional myeloablative conditioning haematopoietic stem cell transplantation for childhood MDS: a report from the MDS working group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S296 - S297
- [25] Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1389 - 1394
- [27] Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50-70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) [J]. BLOOD, 2011, 118 (21) : 843 - 844
- [28] Reduced-Intensity Versus Myeloablative Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 45 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT). [J]. BLOOD, 2012, 120 (21)
- [29] Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JS']JSHCT [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1317 - 1325
- [30] Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JS']JSTCT [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2842 - 2848